
How to Leverage Pricing Governance to Safeguard the Topline
Published on May 11, 2020
How to Leverage Pricing Governance to Safeguard the Topline
Bea Doblas
Mon, 05/11/2020 - 06:49pm
Body
How should pharmaceutical companies navigate the complex global pricing dynamics in the industry and stay in control of their pricing? How can companies ensure that their global pricing is aligned with the company strategy? How should companies set prices and deal with price changes in global markets, considering the impact of International Reference Pricing (IRP)? Robust pricing governance is the solution.
